Efficacy and Safety of Increasing Doses of DaxibotulinumtoxinA for Injection (DAXI for Injection) in the Treatment of Moderate or Severe Lateral Canthal Lines

NCT03911102 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
63
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Revance Therapeutics, Inc.